Copyright
©The Author(s) 2021.
World J Hepatol. Nov 27, 2021; 13(11): 1629-1641
Published online Nov 27, 2021. doi: 10.4254/wjh.v13.i11.1629
Published online Nov 27, 2021. doi: 10.4254/wjh.v13.i11.1629
Approach | Indication | Advantage | Disadvantage |
PVE | Insufficient FLR volume | Percutaneous approach | Contraindicated in patients with extensive portal thrombus and important portal hypertension; Could promote tumoral growth within the embolized liver |
PVL and two-stage hepatectomy | Insufficient FLR volume and treatment of bilobar liver disease | PVL is performed during the first surgical step (tumoral clearance of the FLR) | Surgical procedure; Morbidity |
Associating liver partition and PVL for staged hepatectomy | Insufficient FLR volume +/- treatment of bilobar liver disease | Liver surgery is performed in a short period of time (15 d); First surgical step (PVL and in situ splitting of the liver parenchyma) can be associated with tumoral clearance of the FLR | Surgical procedure; Morbidity |
Sequential trans arterial embolization and PVE | Insufficient FLR volume in patients with hepatocellular carcinoma | Percutaneous approachMay help to counteract the stimulating effect of PVE on tumor growth | Sequential approach (two procedures) is recommended to limit the risk of nontumoral liver ischemic necrosis; Contraindicated in patients with extensive portal thrombus, important portal hypertension or previous biliary surgery (biliodigestive anastomosis) |
Liver venous deprivation | Insufficient FLR volume | Percutaneous approach | Contraindicated in patients with extensive portal thrombus and important portal hypertension; Could promote tumoral growth within the embolized liver |
RL | Insufficient FLR volume | Percutaneous approachConcomitant tumoral control and FLR increaseCan be carried out in patients with portal vein thrombosis | Data reporting liver resection after RL is scarce |
- Citation: Del Basso C, Gaillard M, Lainas P, Zervaki S, Perlemuter G, Chagué P, Rocher L, Voican CS, Dagher I, Tranchart H. Current strategies to induce liver remnant hypertrophy before major liver resection. World J Hepatol 2021; 13(11): 1629-1641
- URL: https://www.wjgnet.com/1948-5182/full/v13/i11/1629.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i11.1629